Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial

By Recker Robert   Lips Paul   Felsenberg Dieter   Lippuner Kurt   Benhamou Laurent   Hawkins Federico   Delmas Pierre D.   Rosen Clifford   Emkey Ronald   Salzmann Gretel   He Weili   Santora Arthur C.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1745-1755

Informa Healthcare

Access to resources Recommend Favorite

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) –– 02

By Orimo Hajime   Nakamura Toshitaka   Fukunaga Masao   Ohta Hiroaki   Hosoi Takayuki   Uemura Yukari   Kuroda Tatsuhiko   Miyakawa Nobuaki   Ohashi Yasuo   Shiraki Masataka    

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1273-1284

Informa Healthcare

Access to resources Recommend Favorite

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women

By Ringe J. D.   Christodoulakos G. E.   Mellström D.   Petto H.   Nickelsen T.   Marín F.   Pavo I.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2677-2687

Informa Healthcare

Access to resources Recommend Favorite

Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis

By Sultana Shaheen   Talegaonkar Sushma   Ali Rashid   Mittal Gaurav   Ahmad Farhan Jalees   Bhatnagar Aseem  

Journal of Microencapsulation, Vol. 29, Iss. 5, 2012-08 ,pp. : 445-454

Informa Healthcare

Access to resources Recommend Favorite

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density

By Bonnick Sydney   Broy Susan   Kaiser Fran   Teutsch Carol   Rosenberg Elizabeth   DeLucca Paul   Melton Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1341-1349

Informa Healthcare

Access to resources Recommend Favorite